# Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line

> **NCT01430546** · — · COMPLETED · sponsor: **Hareth Nahi** · enrollment: 133 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01430546
- **Lead sponsor:** Hareth Nahi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430546, "Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01430546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*